Estados financieros detallados de NextCure, Inc. (NXTC): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $6.03, NXTC presenta beneficios negativos (P/E no significativo) y un ROE del -175.46%. La capitalización bursátil es de $22M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | $6.3M | $22.4M | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $582000 | $1.7M | $34.2M | $46.6M | 0 | 0 | 0 | 0 | $2.2M |
| Beneficio Bruto | -$582000 | -$1.7M | -$27.9M | -$24.2M | 0 | 0 | 0 | 0 | -$2.2M |
| I+D | $13.0M | $19.8M | $34.2M | $46.6M | $50.2M | $54.2M | $47.9M | $41.5M | $44.9M |
| Generales y Administrativos | $2.6M | $3.4M | $9.6M | $17.0M | $20.6M | $21.7M | $19.7M | $15.7M | $12.7M |
| Gastos Operativos | $15.5M | $23.2M | $9.6M | $17.0M | $70.8M | $75.9M | $67.6M | $59.7M | $55.4M |
| Beneficio Operativo | -$15.5M | -$23.2M | -$37.5M | -$41.2M | -$70.8M | -$75.9M | -$67.6M | -$59.7M | -$57.6M |
| EBITDA | -$15.0M | -$21.1M | -$34.8M | -$37.8M | -$65.1M | -$70.6M | -$59.0M | -$54.3M | -$53.7M |
| Gastos por Intereses | 0 | 0 | $209000 | $183000 | $77000 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$15.5M | -$22.8M | -$33.7M | -$36.6M | -$69.4M | -$74.7M | -$62.7M | -$55.7M | -$55.8M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$15.5M | -$22.8M | -$33.7M | -$36.6M | -$69.4M | -$74.7M | -$62.7M | -$55.7M | -$55.8M |
| BPA | $-8.17 | $-12.04 | $-25.79 | $-15.95 | $-30.15 | $-32.32 | $-27.04 | $-23.88 | $-19.65 |
| BPA Diluido | $-8.17 | $-12.04 | $-25.79 | $-15.95 | $-30.15 | $-32.32 | $-27.04 | $-23.88 | $-19.65 |
| Acciones en Circulación (Diluidas) | $1.9M | $1.9M | $1.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.8M |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $8.4M | $135.2M | $34.1M | $32.8M | $12.3M | $26.6M | $13.1M | $27.7M | $26.0M |
| Inversiones a Corto | 0 | 0 | $300.5M | $250.7M | $207.3M | $133.3M | $95.2M | $40.9M | $15.8M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | $700000 | $800000 | $300000 | $100000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | -$700000 | 0 | 0 | 0 |
| Activos Corrientes | $9.4M | $135.8M | $340.0M | $288.0M | $227.8M | $164.0M | $112.7M | $71.8M | $43.7M |
| Inmovilizado Material | $10.0M | $11.4M | $12.1M | $15.8M | $14.0M | $16.9M | $13.4M | $8.7M | $5.9M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $19.5M | $147.6M | $356.2M | $306.6M | $242.4M | $184.2M | $128.0M | $80.9M | $50.2M |
| Cuentas por Pagar | $1.1M | $2.5M | $1.9M | $3.9M | $1.9M | $4.3M | $2.3M | $5.4M | $2.0M |
| Deuda a Corto | $400000 | $387000 | $1.7M | $1.7M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $3.1M | $10.3M | $15.0M | $10.3M | $6.6M | $9.1M | $6.9M | $9.6M | $10.6M |
| Deuda a Largo | $460000 | $73000 | $3.3M | $1.8M | 0 | 0 | 0 | 0 | $4.1M |
| Pasivos Totales | $43.9M | $194.6M | $34.7M | $12.9M | $9.0M | $16.6M | $13.6M | $15.4M | $15.2M |
| Reservas | -$24.5M | -$47.3M | -$81.0M | -$117.6M | -$187.0M | -$261.8M | -$324.5M | -$380.1M | -$436.0M |
| Patrimonio Neto | -$24.4M | -$46.9M | $321.5M | $293.7M | $233.4M | $167.5M | $114.4M | $65.5M | $34.9M |
| Deuda Total | $964000 | $587000 | $5.1M | $3.5M | 0 | $7.1M | $6.6M | $5.9M | $5.2M |
| Deuda Neta | -$7.5M | -$134.6M | -$329.5M | -$280.0M | -$219.6M | -$152.8M | -$101.7M | -$62.7M | -$36.7M |
| Capital Circulante | $6.3M | $125.5M | $325.0M | $277.7M | $221.2M | $154.9M | $105.8M | $62.2M | $33.2M |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$15.5M | -$22.8M | -$33.7M | -$36.6M | -$69.4M | -$74.7M | -$62.7M | -$55.7M | -$55.8M |
| Amortizaciones | $582000 | $1.7M | $2.7M | $3.4M | $7.2M | $4.1M | $3.7M | $2.9M | $1.7M |
| Compensación en Acciones | $75000 | $263000 | $1.9M | $7.9M | $10.3M | $9.5M | $8.2M | $6.3M | $3.0M |
| Cambio en Capital Circulante | $2.3M | $28.9M | -$6.5M | -$19.7M | -$5.3M | $3.7M | -$1.9M | $4.5M | $954000 |
| Flujo de Caja Operativo | -$12.5M | $8.0M | -$35.6M | -$45.0M | -$57.2M | -$53.9M | -$53.0M | -$40.8M | -$49.6M |
| Inversiones (CapEx) | -$8.7M | -$3.1M | -$3.4M | -$7.1M | -$2.4M | -$2.1M | -$820000 | -$474000 | 0 |
| Adquisiciones | 0 | 0 | 0 | -$50655 | -$38961 | -$70095 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$21.2M | $4.9M | -$39.0M | -$52.1M | -$59.6M | -$56.0M | -$53.8M | -$41.3M | -$49.6M |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +252.6% | -100.0% | |||||||
| Crecimiento Beneficio Neto (anual) | -47.4% | -48.0% | -8.5% | -89.6% | -7.7% | +16.1% | +11.3% | -0.3% | |
| Crecimiento BPA (anual) | -47.4% | -114.2% | +38.1% | -89.0% | -7.2% | +16.3% | +11.7% | +17.7% | |
| Cambio en Acciones (anual) | +0.0% | -30.9% | +75.4% | +0.3% | +0.5% | +0.3% | +0.5% | +22.0% | |
| Crecimiento FCF (anual) | +123.3% | -891.1% | -33.6% | -14.4% | +6.0% | +3.9% | +23.3% | -20.2% | |
| Margen Bruto | -439.1% | -108.0% | |||||||
| Margen Operativo | -590.5% | -184.2% | |||||||
| Margen EBITDA | -548.2% | -169.0% | |||||||
| Margen Neto | -531.5% | -163.6% | |||||||
| Margen FCF | -614.4% | -232.8% | |||||||
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-11.18 | $2.60 | $-29.81 | $-22.70 | $-25.90 | $-24.22 | $-23.19 | $-17.71 | $-17.45 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1.9M | $1.9M | $1.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.8M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -175.46% |
| Rentabilidad sobre capital invertido | -259.91% |
| Rentabilidad sobre activos | -188.98% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.35 |
| Ratio corriente | 3.47 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| P/E | -29.22 | -19.83 | -26.21 | -8.20 | -2.39 | -0.52 | -0.51 | -0.39 | -0.72 |
| P/VC | -18.52 | -9.63 | 2.75 | 1.02 | 0.71 | 0.23 | 0.28 | 0.33 | 1.15 |
| P/V | 0.00 | 0.00 | 139.30 | 13.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | -439.1% | -108.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | -590.5% | -184.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | -531.5% | -163.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: ANTX · BOLD · INTS · ITRM · JSPR · PLUR · PSTV
Explorar sector: Healthcare · Biotechnology
Más secciones de NXTC: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones